These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11096408)

  • 21. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials--multiple treatments, multiple end points, and multiple lessons.
    Lauer MS; Topol EJ
    JAMA; 2003 May; 289(19):2575-7. PubMed ID: 12759328
    [No Abstract]   [Full Text] [Related]  

  • 24. Validity of the MAGIC study: sufficient for recommendations?
    Bauer K; Porzsolt F; Henne-Bruns D
    Hepatogastroenterology; 2013 Oct; 60(127):1822-4. PubMed ID: 24624448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo group needed for interpretation of combination trial.
    El-Mallakh RS; Kaur G; Lippman S
    Am J Psychiatry; 2010 Aug; 167(8):996; author reply 996-7. PubMed ID: 20693473
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
    Shan G; Ma C; Hutson AD; Wilding GE
    J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current development in clinical trials: issues old and new.
    DeMets DL
    Stat Med; 2012 Nov; 31(25):2944-54. PubMed ID: 22736410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 30. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.
    Ferrucci L; Guralnik JM; Studenski S; Fried LP; Cutler GB; Walston JD;
    J Am Geriatr Soc; 2004 Apr; 52(4):625-34. PubMed ID: 15066083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Problems and strategies in clinical trials of traditional Chinese medicine].
    Li TQ; Wang G; Wang L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Apr; 26(4):298-302. PubMed ID: 16688993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationality and the generalization of randomized controlled trial evidence.
    Fuller J
    J Eval Clin Pract; 2013 Aug; 19(4):644-7. PubMed ID: 23368415
    [No Abstract]   [Full Text] [Related]  

  • 33. Reporting attrition in randomised controlled trials.
    Dumville JC; Torgerson DJ; Hewitt CE
    BMJ; 2006 Apr; 332(7547):969-71. PubMed ID: 16627519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials.
    Anderson JR; Krailo M
    Am J Bioeth; 2011 Mar; 11(3):18-9. PubMed ID: 21400379
    [No Abstract]   [Full Text] [Related]  

  • 35. The Primary Outcome Is Positive - Is That Good Enough?
    Pocock SJ; Stone GW
    N Engl J Med; 2016 Sep; 375(10):971-9. PubMed ID: 27602669
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges in the Design and Interpretation of Noninferiority Trials.
    Mauri L; D'Agostino RB
    N Engl J Med; 2017 Oct; 377(14):1357-1367. PubMed ID: 28976859
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized controlled trials: methodological concepts and critique.
    Salmond SS
    Orthop Nurs; 2008; 27(2):116-22; quiz 123-4. PubMed ID: 18385595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A statistic to avoid being misled by the "winners curse".
    Tugwell P; Knottnerus JA
    J Clin Epidemiol; 2018 Nov; 103():vi-viii. PubMed ID: 30293635
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized control trial of immunosuppression in paraquat poisoning.
    Gunawardena G; Roberts DM; Buckley NA
    Crit Care Med; 2007 Jan; 35(1):330-1; author reply 331. PubMed ID: 17197797
    [No Abstract]   [Full Text] [Related]  

  • 40. How They Did It: Increasing Transparency for Randomized Trial Methods.
    Brubaker L
    Female Pelvic Med Reconstr Surg; 2016; 22(4):181. PubMed ID: 27337409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.